Evidence map›Paper›PMID 23819686›Full record

ArticleBiotechnology for biofuels2013

Addition of a carbohydrate-binding module enhances cellulase penetration into cellulose substrates.

Vimalier Reyes-Ortiz, Richard A Heins, Gang Cheng, Edward Y Kim, Briana C Vernon, Ryan B Elandt, Paul D Adams, Kenneth L Sale, Masood Z Hadi, Blake A Simmons and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Novel Endotype Xanthanase from Xanthan-DegradingApplied and environmental microbiology · 2019
    Article
  13. EngineeringBiotechnology for biofuels · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Lipopeptide produced fromBiotechnology for biofuels · 2017
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Vimalier Reyes-OrtizDeconstruction Division, Joint BioEnergy Institute, Emeryville, CA 94608, US. dtercek@berkeley.edu.
Richard A Heins
Gang Cheng
Edward Y Kim
Briana C Vernon
Ryan B Elandt
Paul D Adams
Kenneth L Sale
Masood Z Hadi
Blake A Simmons
Michael S Kent
Danielle Tullman-Ercek
Joint BioEnergy Institute · USSandia National Laboratories · USSandia National Laboratories California · USUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCellulases are of great interest for application in biomass degradation, yet the molecular details of the mode of action of glycoside hydrolases during degradation of insoluble cellulose remain elusive. To further improve these enzymes for application at industrial conditions, it is critical to gain a better understanding of not only the details of the degradation process, but also the function of accessory modules.

methodWe fused a carbohydrate-binding module (CBM) from family 2a to two thermophilic endoglucanases. We then applied neutron reflectometry to determine the mechanism of the resulting enhancements.

resultsCatalytic activity of the chimeric enzymes was enhanced up to three fold on insoluble cellulose substrates as compared to wild type. Importantly, we demonstrate that the wild type enzymes affect primarily the surface properties of an amorphous cellulose film, while the chimeras containing a CBM alter the bulk properties of the amorphous film.

conclusionOur findings suggest that the CBM improves the efficiency of these cellulases by enabling digestion within the bulk of the film.

Identifiers

PMID23819686
PMCPMC3716932
OpenAlexW2138785951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.